SCHOTT Pharma AG & Co. KGaA (1SXP.F)
EUR 22.55
(-0.22%)
EUR 22.55
(-0.22%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.23 Billion EUR | 2.95% |
| 2022 | 1.19 Billion EUR | 61.71% |
| 2021 | 739.89 Million EUR | 24.14% |
| 2020 | 596.01 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.39 Billion EUR | 2.94% |
| 2024 Q2 | 1.35 Billion EUR | 9.48% |
| 2024 Q1 | 1.24 Billion EUR | 0.77% |
| 2023 Q4 | 1.23 Billion EUR | 6.83% |
| 2023 FY | 1.23 Billion EUR | 2.95% |
| 2023 Q3 | 1.15 Billion EUR | 0.0% |
| 2023 Q2 | - EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2022 FY | 1.19 Billion EUR | 61.71% |
| 2022 Q4 | 1.19 Billion EUR | 0.0% |
| 2021 FY | 739.89 Million EUR | 24.14% |
| 2020 FY | 596.01 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Carl Zeiss Meditec AG | 3.03 Billion EUR | 59.385% |
| Fielmann Aktiengesellschaft | 2.13 Billion EUR | 42.323% |
| Gerresheimer AG | 3.42 Billion EUR | 64.078% |
| Sartorius Aktiengesellschaft | 9.75 Billion EUR | 87.373% |
| Sartorius Aktiengesellschaft | 9.75 Billion EUR | 87.373% |